TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS September 27, 1991